Skip to main content

Advertisement

SpringerLink
Log in

Sericin Inhibits Devitrification of Amorphous Drugs

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of the present investigation was to analyze devitrification of amorphous drugs such as lornoxicam, meloxicam, and felodipine in the presence of sericin. The binary solid dispersions comprising varying mass ratios of drug and sericin were subject to amorphization by spray drying, solvent evaporation, ball milling, and physical mixing. Further, obtained solid dispersions (SDs) were characterized by HPLC, ATR-FTIR, H1NMR, molecular docking, accelerated stability study at 40°C and 75 ± 2% RH (XRD and DSC), and in vitro dissolution studies. The HPLC analysis indicated no decomposition of the drugs during the spray drying process. From ATR-FTIR, NMR, and molecular docking study, it was revealed that H-bonding played a vital role in amorphous drug stabilization. An excellent devitrification inhibition was observed in case of lornoxicam (SDLS3) and meloxicam (SDMS3) SDs prepared by spray drying. On the other hand, spray-dried SD of felodipine (SDFS3) showed traces of microcrystals. The percent crystallinity of SDLS3, SDMS3, and SDFS3 was found to be 7.4%, 8.23%, and 18.31% respectively indicating adequate amorphization. The dissolution performance of SDLS, SDMS, and SDFS after 3 months showed > 85% than SDs prepared by other methods. Thus, sericin significantly inhibited crystallization and was responsible for amorphous state stabilization of pharmaceuticals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50:47–60. http://www.ncbi.nlm.nih.gov/pubmed/10840192.

    CAS  PubMed  Google Scholar 

  2. Serajuddln ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88:1058–66.

    Google Scholar 

  3. Zhou D, Zhang GGZ, Law D, Grant DJW, Schmitt EA. Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility. J Pharm Sci. 2002;91:1863–72.

    CAS  PubMed  Google Scholar 

  4. Graeser KA, Patterson JE, Zeitler JA, Gordon KC, Rades T. Correlating thermodynamic and kinetic parameters with amorphous stability. Eur J Pharm Sci. 2009;37:492–8.

    CAS  PubMed  Google Scholar 

  5. Ahlneck C, Zografi G. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm. 1990;62:87–95.

    CAS  Google Scholar 

  6. Yoshioka M, Hancock BC, Zografi G. Crystallization of lndomethacin from the amorphous state below and above its glass transition temperature. J Pharm Sci. 1994;83:1700–5.

    CAS  PubMed  Google Scholar 

  7. Trasi NS, Purohit HS, Taylor LS. Evaluation of the crystallization tendency of commercially available amorphous tacrolimus formulations exposed to different stress conditions. Pharm Res. 2017;34:2142–55.

    CAS  PubMed  Google Scholar 

  8. Baghel S, Cathcart H, O’Reilly NJ. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci Elsevier Ltd. 2016;105:2527–44. Available from: https://doi.org/10.1016/j.xphs.2015.10.008.

    CAS  PubMed  Google Scholar 

  9. Hancock B, Shamblin S, Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res. 1995;12:799–806.

    CAS  PubMed  Google Scholar 

  10. Pokharkar VB, Mandpe LP, Padamwar MN, Ambike AA, Mahadik KR, Paradkar A. Development, characterization and stabilization of amorphous form of a low Tg drug. Powder Technol. 2006;167:20–5.

    CAS  Google Scholar 

  11. Matsumoto T, Zografi G. Physical properties of solid molecular dispersions of indomethacin with poly (vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res. 1999;16:1722–8.

    CAS  PubMed  Google Scholar 

  12. Pignatello R, Spadaro D, Vandelli MA, Forni F, Puglisi G. Characterization of the mechanism of interaction in ibuprofen-Eudragit RL100 coevaporates. Drug Dev Ind Pharm. 2004;30:277–88. http://www.ncbi.nlm.nih.gov/pubmed/15109027.

    CAS  PubMed  Google Scholar 

  13. Shakhtshneider TP, De FDÀ, Capet F, Willart JF, Descamps M, S a M, et al. Grinding of drugs with pharmaceutical excipients at cryogenic temperatures part I. Cryogenic grinding of piroxicam – polyvinylpyrrolidone mixtures. J Therm Anal Calorim. 2007;89:699–707.

    CAS  Google Scholar 

  14. Shakhtshneider TP, Danède F, Capet F, Willart JF, Descamps M, Paccou L, et al. Grinding of drugs with pharmaceutical excipients at cryogenic temperatures. J Therm Anal Calorim. 2007;89:709–15.

    CAS  Google Scholar 

  15. Mulye SP, Jamadar SA, Karekar PS, Pore YV, Dhawale SC. Improvement in physicochemical properties of ezetimibe using a crystal engineering technique. Powder Technol Elsevier BV. 2012;222:131–8. Available from: https://doi.org/10.1016/j.powtec.2012.02.020.

    CAS  Google Scholar 

  16. Fu Q, Fang M, Hou Y, Yang W, Shao J, Guo M, et al. A physically stabilized amorphous solid dispersion of nisoldipine obtained by hot melt extrusion. Powder Technol. 2016;301:342–8.

    CAS  Google Scholar 

  17. Bhende S, Jadhav N. Moringa coagulant as a stabilizer for amorphous solids: part I. AAPS PharmSciTech. 2012;13:400–10. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3364398&tool=pmcentrez&rendertype=abstract.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Shilpi D, Kushwah V, Agrawal AK, Jain S. Improved stability and enhanced oral bioavailability of atorvastatin loaded stearic acid modified gelatin nanoparticles. Pharm Res. 2017;34:1505–16.

    CAS  PubMed  Google Scholar 

  19. Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, et al. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci. 2001;12:261–9.

    PubMed  Google Scholar 

  20. Knopp MM, Olesen NE, Holm P, Langguth P, Holm R, Rades T. Influence of polymer molecular weight on drug-polymer solubility: a comparison between experimentally determined solubility in PVP and prediction derived from solubility in monomer. J Pharm Sci. 2015;104:2905–12.

    CAS  PubMed  Google Scholar 

  21. Zhang P, Forsgren J, Strømme M. Stabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugs. Int J Pharm Elsevier BV. 2014;472:185–91. Available from: https://doi.org/10.1016/j.ijpharm.2014.06.025.

    CAS  PubMed  Google Scholar 

  22. Lin S, Cheng C. Solid state interaction studies of drug-polymers (II): warfarin-Eudragit E, RL or S resins Shan-Yang. Eur J Pharm Sci. 1994;1:313–22.

    CAS  Google Scholar 

  23. Bley H, Fussnegger B, Bodmeier R. Characterization and stability of solid dispersions based on PEG/polymer blends. Int J Pharm Elsevier BV. 2010;390:165–73. Available from: https://doi.org/10.1016/j.ijpharm.2010.01.039.

    CAS  PubMed  Google Scholar 

  24. Vasa DM, Dalal N, Katz JM, Roopwani R, Nevrekar A, Patel H, et al. Physical characterization of drug: polymer dispersion behavior in polyethylene glycol 4000 solid dispersions using a suite of complementary analytical techniques. J Pharm Sci. 2014;103:2911–23.

    CAS  PubMed  Google Scholar 

  25. Ueda H, Aikawa S, Kashima Y, Kikuchi J, Ida Y, Tanino T, et al. Anti-plasticizing effect of amorphous indomethacin induced by specific intermolecular interactions with PVA copolymer. J Pharm Sci Elsevier Masson SAS. 2014;103:2829–38. Available from: https://doi.org/10.1002/jps.24023.

    CAS  PubMed  Google Scholar 

  26. Shimpi SL, Chauhan B, Mahadik KR, Paradkar A. Stabilization and improved in vivo performance of amorphous etoricoxib using Gelucire 50/13. Pharm Res. 2005;22:1727–34.

    CAS  PubMed  Google Scholar 

  27. Sarode AL, Malekar SA, Cote C, Worthen DR. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine. Carbohydr Polym Elsevier Ltd. 2014;112:512–9. Available from: https://doi.org/10.1016/j.carbpol.2014.06.039.

    CAS  PubMed  Google Scholar 

  28. Konno H, Taylor LS. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci. 2006;95:2692–705.

    CAS  PubMed  Google Scholar 

  29. Liu J, Cao F, Zhang C, Ping Q. Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion. Acta Pharm Sin B. 2013;3:263–72. http://www.sciencedirect.com/science/article/pii/S2211383513000646.

    Google Scholar 

  30. Aramwit P. Effectiveness of inflammatory cytokines induced by sericin compared to sericin in combination with silver sulfadiazine cream on wound healing. Wounds. 2009;21:198–206.

    PubMed  Google Scholar 

  31. Aramwit P, Keongamaroon O, Siritientong T, Bang N, Supasyndh O. Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study. BMC Nephrol. 2012;13:119. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3472272&tool=pmcentrez&rendertype=abstract.

    PubMed  PubMed Central  Google Scholar 

  32. Kitisin T, Maneekan P, Luplertlop N. In-vitro characterization of silk sericin as an anti-aging agent. J Agric Sci. 2013;5:54–63.

    Google Scholar 

  33. Zhaorigetu S, Yanaka N, Sasaki M, Watanabe H, Kato N. Inhibitory effects of silk protein, sericin on UVB-induced acute damage and tumor promotion by reducing oxidative stress in the skin of hairless mouse. J Photochem Photobiol B Biol. 2003;71:11–7.

    CAS  Google Scholar 

  34. Takasu Y, Yamada H, Tsubouchi K. Isolation of three main sericin components from the cocoon of the silkworm, Bombyx mori. Biosci Biotechnol Biochem. 2002;66:2715–8.

    CAS  PubMed  Google Scholar 

  35. Tao W, Li M, Xie R. Preparation and structure of porous silk sericin materials. Macromol Mater Eng. 2005;290:188–94.

    CAS  Google Scholar 

  36. Aramwit P, Siritientong T, Srichana T. Potential applications of silk sericin, a natural protein from textile industry by-products. Waste Manag Res. 2012;30:217–24. http://www.researchgate.net/publication/51113185_Potential_applications_of_silk_sericin_a_natural_protein_from_textile_industry_by-products.

    CAS  PubMed  Google Scholar 

  37. Morikawa M, Kimura T, Murakami M, Katayama K, Terada S, Yamaguchi A. Rat islet culture in serum-free medium containing silk protein sericin. J Hepato-Biliary-Pancreat Surg. 2009;16:223–8.

    Google Scholar 

  38. Terada S, Nishimura T, Sasaki M, Yamada H, Miki M. Sericin, a protein derived from silkworms, accelerates the proliferation of several mammalian cell lines including a hybridoma. Cytotechnology. 2003;40:3–12.

    Google Scholar 

  39. Tsujimoto K, Takagi H, Takahashi M, Yamada H, Nakamori S, Tagaki H, et al. Cryoprotective effect of the serine-rich repetitive sequence in silk protein sericin. J Biochem. 2001;986:979–86.

    Google Scholar 

  40. Salunkhe NH, Jadhav NR, More HN, Jadhav AD. Screening of drug-sericin solid dispersions for improved solubility and dissolution. Int J Biol Macromol Elsevier BV. 2018;107:1683–91. Available from. https://doi.org/10.1016/j.ijbiomac.2017.10.035.

    Article  CAS  Google Scholar 

  41. Zhang YQ. Applications of natural silk protein sericin in biomaterials. Biotechnol Adv. 2002;20:91–100.

    CAS  PubMed  Google Scholar 

  42. Rawlinson CF, Williams AC, Timmins P, Grimsey I. Polymer-mediated disruption of drug crystallinity. Int J Pharm. 2007;336:42–8.

    CAS  PubMed  Google Scholar 

  43. Deodware SA, Sathe DJ, Choudhari PB, Lokhande TN, Gaikwad SH. Development and molecular modeling of Co(II), Ni(II) and Cu(II) complexes as high acting anti breast cancer agents. Arab J Chem The Authors. 2017;10:262–72. Available from: https://doi.org/10.1016/j.arabjc.2016.09.024.

    CAS  Google Scholar 

  44. Abhale YK, Shinde AD, Deshmukh KK, Nawale L, Sarkar D, Choudhari PB, et al. Synthesis, antimycobacterial screening and molecular docking studies of 4-aryl-4′-methyl-2′-aryl-2,5′-bisthiazole derivatives. Med Chem Res Springer US. 2017;26:1–11. Available from: https://doi.org/10.1007/s00044-017-1988-5.

    CAS  Google Scholar 

  45. Patravale AA, Gore AH, Kolekar GB, Deshmukh MB, Choudhari PB, Bhatia MS, et al. Synthesis, biological evaluation and molecular docking studies of some novel indenospiro derivatives as anticancer agents. J Taiwan Inst Chem Eng Elsevier BV. 2016;68:105–18. Available from: https://doi.org/10.1016/j.jtice.2016.09.034.

    CAS  Google Scholar 

  46. Shibata YFM, Kokudai M, Noda S, Okada H, Kondoh M, Watanabe Y. Effect of characteristics of compounds on maintenance of an amorphous state in solid dispersion with crospovidone. J Pharm Sci. 2007;96:1537–47.

    CAS  PubMed  Google Scholar 

  47. Savolainen M, Kogermann K, Heinz A, Aaltonen J, Peltonen L, Strachan C, et al. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy. Eur J Pharm Biopharm Elsevier BV. 2009;71:71–9. Available from: https://doi.org/10.1016/j.ejpb.2008.06.001.

    CAS  PubMed  Google Scholar 

  48. Ahmed MO, Al-Badr AA. Lornoxicam. 1st ed. profiles drug Subst. Excipients Relat. Methodol. Elsevier Inc.; 2011. Available from: https://doi.org/10.1016/B978-0-12-387667-6.00006-3.

    Google Scholar 

  49. Ozaki S, Minamisono T, Yamashita T, Kato T, Kushida I. Supersaturation–nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms. J Pharm Sci. 2012;101:214–22.

    CAS  PubMed  Google Scholar 

  50. Ozaki S, Kushida I, Yamashita T, Hasebe T, Shirai O, Kano K. Evaluation of drug supersaturation by thermodynamic and kinetic approaches for the prediction of oral absorbability in amorphous pharmaceuticals. J Pharm Sci. 2012;101:4220–30.

    CAS  PubMed  Google Scholar 

  51. Ozaki S, Kushida I, Yamashita T, Hasebe T, Shirai O, Kano K. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs. J Pharm Sci. 2013;102:2273–81.

    CAS  PubMed  Google Scholar 

  52. Saboo S, Mugheirbi NA, Zemlyanov DY, Kestur US, Taylor LS. Congruent release of drug and polymer: a “sweet spot” in the dissolution of amorphous solid dispersions. J Control Release Elsevier BV. 2019;298:68–82. Available from. https://doi.org/10.1016/j.jconrel.2019.01.039.

    Article  CAS  Google Scholar 

  53. Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 2004;272:1–10.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Adarsh College of Pharmacy, Vita, Maharashtra state, 415311, India

    Nitin Salunkhe

  2. Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Kolhapur, Maharashtra state, 416013, India

    Namdeo Jadhav, Harinath More & Prafulla Choudhari

Authors
  1. Nitin Salunkhe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Namdeo Jadhav
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Harinath More
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prafulla Choudhari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Namdeo Jadhav.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salunkhe, N., Jadhav, N., More, H. et al. Sericin Inhibits Devitrification of Amorphous Drugs. AAPS PharmSciTech 20, 285 (2019). https://doi.org/10.1208/s12249-019-1475-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/s12249-019-1475-z

KEY WORDS

Search

Navigation